Newsroom-Katalog

Zeit	Boehringer Ingelheim: Meldungen vom 25.09.2008
09:09	Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window